NYSTATIN
Generic: NYSTATIN
NYSTATIN is FDA application ANDA213566, sponsored by MACLEODS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Subpotent: Out of specification for assay at the 12-month time point.
Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.
Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability
Subpotent drug: Out of specification for assay at the 15-month test interval.
Resuspension problems: Out of specification for appearance and resuspendability.
SubPotent Drug: Low out-of-specification results for assay testing.
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Failed Stability Specifications
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of cont